The Guilty Gilt Guide was written with a clear objective – to maximize the whole-herd performance of pig populations by helping gilts to reach their full reproductive potential and produce healthy pigs that reach their full genetic potential during grow-finish.
The open reading frames (ORF)5 represents approximately 4% of the porcine repro- ductive and respiratory syndrome virus (PRRSV)-2 genome (whole-PRRSV) and is often determined by the Sanger technique, which rarely detects >1 PRRSV strain if present in the sample.
Porcine reproductive and respiratory syndrome virus (PRRSV) is an important swine pathogen affecting the global swine industry.
Mycoplasma hyopneumoniae (M. hyopneumoniae) infections continue to result in significant respiratory challenges in the swine industry worldwide. Vaccination for M. hyopneumoniae is commonly utilized, as reduction in bacterial loads and clinical severity in vaccinated pigs have been shown. However, the effect of M. hyopneumoniae vaccination on transmission across different pig populations has been minimally investigated.
Don’t miss any news on PRRS disease control Subscribe now to PRRS.com newsletter
The results of this study demonstrated that Ingelvac® PRRS MLV vaccine had a significantly better efficacy in grower-finisher pigs.
The results of this study demonstrated poor efficacy performance using Type I vaccine in the farm positive for PRRSV type II compared to a VR2332 based vaccine.
In conclusion, Ingelvac® PRRS MLV is a useful tool to control and prevent PHFD.
Ingelvac® PRRS MLV vaccination program and health management are essential to achieve good performance in PRRS positive farms.